BIO-key International - BKYI Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.80
▲ +0.02 (2.57%)

This chart shows the closing price for BKYI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New BIO-key International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BKYI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BKYI

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for BIO-key International in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.80.

This chart shows the closing price for BKYI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in BIO-key International. This rating has held steady since March 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/6/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/4/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/29/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/28/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/26/2021Maxim GroupUpgradeHold ➝ Buy$6.00High
8/11/2020Maxim GroupReiterated RatingHoldHigh
10/4/2019Maxim GroupDowngradeBuy ➝ HoldLow
8/30/2019Maxim GroupSet TargetBuy$2.00Low
7/29/2019Maxim GroupReiterated RatingBuy$2.25Low
4/2/2019Maxim GroupReiterated RatingBuy$4.00Low
11/15/2018Maxim GroupReiterated RatingBuy$4.00Medium
8/16/2018Maxim GroupLower TargetBuy ➝ Buy$5.50 ➝ $5.00Low
4/24/2018Maxim GroupInitiated CoverageBuy ➝ Buy$5.50Medium
3/29/2018Maxim GroupSet TargetBuy$6.00High
(Data available from 1/29/2018 forward)

News Sentiment Rating

1.33 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/3/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/2/2022
  • 5 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/1/2022
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/1/2022
  • 6 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/31/2022
  • 6 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/30/2022
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/30/2022
  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/29/2023

Current Sentiment

  • 5 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
BIO-key International logo
BIO-key International, Inc. engages in the provision of identity and access management (IAM) platform.The firm's products include multi-factor authentication, self-service password reset, single sign-on, fingerprint scanners, and civil and large-scale identification.It offers its services to the education, financial, government, healthcare, manufacturing, and retail industries.The company was founded on January 7, 1993 and is headquartered in Wall, NJ.
Read More

Today's Range

Now: $0.80
Low: $0.73
High: $0.80

50 Day Range

MA: $0.79
Low: $0.54
High: $1.08

52 Week Range

Now: $0.80
Low: $0.52
High: $2.90

Volume

23,502 shs

Average Volume

18,003 shs

Market Capitalization

$6.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.85

Frequently Asked Questions

What sell-side analysts currently cover shares of BIO-key International?

The following Wall Street sell-side analysts have issued reports on BIO-key International in the last twelve months:
View the latest analyst ratings for BKYI.

What is the current price target for BIO-key International?

0 Wall Street analysts have set twelve-month price targets for BIO-key International in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for BIO-key International in the next year.
View the latest price targets for BKYI.

What is the current consensus analyst rating for BIO-key International?

BIO-key International currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for BKYI.

What other companies compete with BIO-key International?

Other companies that are similar to BIO-key International include Cyren, Amesite, Infobird, My Size and Safe-T Group. Learn More about companies similar to BIO-key International.

How do I contact BIO-key International's investor relations team?

BIO-key International's physical mailing address is 3349 HIGHWAY 138 BUILDING A SUITE E, WALL NJ, 07719. The technology company's listed phone number is (732) 359-1100 and its investor relations email address is [email protected] The official website for BIO-key International is www.bio-key.com. Learn More about contacing BIO-key International investor relations.